SCHEMBL24401162

SCHEMBL24401162

CCOC(=O)c1cc2nc(C=C3CCN(C(=O)OC(C)(C)C)CC3)n(C[C@@H]3CCO3)c2s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.39
GPR119 Q8TDV5 3/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
ALDH1A1 P00352 4/20 0.36
GAA P10253 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GRM5 P41594 1/20 0.35
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ALOX15 P16050 1/20 0.34
RECQL P46063 1/20 0.33
EED O75530 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24401166 0.87 ADORA1 (0.39) ADORA1GPR119TP53POLBALDH1A1
SCHEMBL24401165 0.85 TSHR (0.33) ALDH1A1GAAMEN1LMNAKMT2A
SCHEMBL30938745 0.81 ALDH1A1 (0.42) ADORA1GPR119TP53POLBALDH1A1
SCHEMBL22550750 0.81 ALDH1A1 (0.42) ADORA1GPR119TP53POLBALDH1A1
SCHEMBL29262336 0.81 ALDH1A1 (0.42) ADORA1GPR119TP53POLBALDH1A1
SCHEMBL29149786 0.77 PKM (0.39) GPR119TP53ALDH1A1GRM5MAPT
SCHEMBL29149793 0.77 PKM (0.39) GPR119TP53ALDH1A1GRM5MAPT
SCHEMBL30680774 0.77 PKM (0.39) GPR119TP53ALDH1A1GRM5MAPT
SCHEMBL30680670 0.77 PKM (0.39) GPR119TP53ALDH1A1GRM5MAPT
SCHEMBL29924743 0.76 GLP1R (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203057-A1 FIVE-MEMBERED HETEROAROMATIC IMIDAZOLE COMPOUND AND USE THEREOF HANGZHOU SCIWIND BIOSCIENCES CO., LTD (CN) 2023-06-29 US disclosed
US-11542272-B2 Five-membered heteroaryl-fused imidazole compound and application thereof HANGZHOU SCIWIND BIOSCIENCES CO., LTD (CN) 2023-01-03 US disclosed
US-20220135588-A1 Five-Membered Heteroaryl-Fused Imidazole Compound And Application Thereof HANGZHOU SCIWIND BIOSCIENCES CO., LTD (CN) 2022-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220135588-A1 Five-Membered Heteroaryl-Fused Imidazole Compound And Application Thereof GLP1R, GIPR, GPR119 ADORA1 1439/4885GPR119 3/4885TP53 4692/4885
US-20230203057-A1 FIVE-MEMBERED HETEROAROMATIC IMIDAZOLE COMPOUND AND USE THEREOF GLP1R, GIPR, GPR119 ADORA1 1083/4885GPR119 3/4885TP53 4663/4885
US-11542272-B2 Five-membered heteroaryl-fused imidazole compound and application thereof GLP1R, GIPR, GPR119 ADORA1 1439/4885GPR119 3/4885TP53 4692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.